Our New Manufacturing Facility
The manufacturing facility is located in Connecticut. It is BRC Certified (GFSI), and it uses state-of-the-art electronics that are a servo-driven, computer-controlled, modular, and it has a pouching system for Immunocal and Immunocal Platinum.
The British Retail Consortium (BRC) was founded in 1996 in an effort to standardize the supply chain and safety standards globally. A facility that has BRC certification, meets international Food Safety Management Systems standards, also becoming a GFSI recognized facility that follows the requirements for food processors to build an effective food safety management system. Global Food Safety Initiative (GFSI) is a global food network consisting of approximately 400 retailers and manufacturers worldwide.
Dr. Gustavo Bounous
Dr. Bounous developed the method to produce a specific whey protein which was given the proprietary name Immunocal. It has become the standard by which all other whey products have to be measured.
Educated at the University of Turin and the University of Genoa in his native Italy, Dr. Bounous' distinguished career in medical research began as a research fellow in surgery at the Indiana Medical Center, Indianapolis. In 1963, he moved to Canada and began an academic career that led him to becoming Professor of Surgery, first at the University of Sherbrooke (1973-1985) and then at McGill University (1985-1993).
Dr. Bounous was awarded the 1965 medal of the Royal College of Physicians and Surgeons of Canada. He pioneered the use of elemental diets in the prophylaxis and treatment of intestinal lesions associated with shock, intestinal ischemia, radiation, cancer chemotherapy and Crohn's disease. In 1968, he was named Career Investigator of the Medical Research Council, an award that was reconfirmed until 1993, the year of his retirement from McGill University.
In addition to being honored as a Career Investigator of the Canadian Research Council, Dr. Bounous is a recipient of the Medal of Royal College of Physicians and a lifetime member of the Research Council of Canada.
Dr. Patricia Kongshavn
Patricia Kongshavn received her honors degree in Natural Sciences as a Major Scholar at Cambridge University, and completed her doctorate in Immunology at McGill University after immigrating to Canada. She subsequently joined the Faculty of Medicine at McGill University and held appointments in the Departments of Physiology and Medicine, becoming full professor in 1986. Her research was funded by independent grants from the Medical Research Council of Canada, the National Cancer Institute of Canada and the National Institutes of Health in the United States.
Her main research was concerned with increasing basic knowledge of the immune system, with a focus on cellular immunology, host/parasite interactions and the genetics of natural resistance.
In the mid-1970’s she began collaboration initiated by Dr. Gustavo Bounous to research the influence of various dietary proteins on immune responsiveness. They published their first paper on this research in 1978 and continued their collaboration until 1989, during which period they co-authored 14 papers. This work led to the discovery of the whey protein concentrate that regulated glutathione levels and promoted immune enhancing activity. This led ultimately to the production of the high-quality natural product: IMMUNOCAL.
Dr. Kongshavn retired from McGill, relocating to the West in 1990 where she continues to consult and lecture on related topics.
Dr. Wulf Dröge
Dr. Dröge devoted more than forty years to basic and clinical research and almost 30 as a professor of immunology and cell biology at the University of Heidelberg and head of the Department of Immunochemistry at the National Cancer Research Center of Germany. In 1986 Dr. Dröge was the first to describe the effect of glutathione on the immune response of a living organism and later discovered the abnormally low cysteine and glutathione levels in HIV patients. He also actively engaged in the design of clinical studies and also organized research activities at McGill University and other leading scientific institutions like the Max-Planck Institute of Immunobiology in Freiburg, Germany, and the University of Minnesota.
His international reputation in the field of redox physiology and aging research is based on more than 280 publications in international scientific journals. He focused his research in the areas of redox regulation and signaling pathways, pathogenesis of HIV infection, the mechanisms of disease-related wasting and aging, and the action of tumor necrosis factor. He also published many articles in the fields of redox physiology, cancer, and aging research and regularly gave student lectures at McGill University in Montreal.
His work ethic set the standard for the formulation of safe and effective new Immunotec products such as Immunocal Platinum.